Recombinant Haemophilus influenzae Uncharacterized protein HI_1495 (HI_1495)

Shipped with Ice Packs
In Stock

Description

Production and Purification

Expressed in Escherichia coli with the following specifications :

ParameterDetail
Expression SystemE. coli
TagHexahistidine (His-tag)
Purification MethodAffinity chromatography (Ni-NTA)
Purity>90% (SDS-PAGE verified)
FormulationLyophilized powder in Tris/PBS buffer with 6% trehalose (pH 8.0)
Reconstitution0.1–1.0 mg/mL in sterile water; 5–50% glycerol recommended for long-term storage

Applications

  • SDS-PAGE analysis: Primary application for protein size verification .

  • Antigen production: Potential use in antibody generation due to its bacterial origin .

  • Functional studies: Enables exploration of HI_1495’s role in H. influenzae physiology, particularly in multidrug-resistant strains .

Research Significance

Despite its uncharacterized status, HI_1495 represents a component of H. influenzae’s proteome—a pathogen causing global morbidity with rising antibiotic resistance . The recombinant protein’s availability facilitates:

  • Structural studies (e.g., crystallography or cryo-EM) to elucidate its 3D conformation .

  • Interaction assays to identify binding partners.

  • Vaccine development efforts targeting non-typeable H. influenzae strains .

Current research gaps include its role in bacterial virulence, metabolic pathways, or resistance mechanisms. The protein’s small size and lack of homology to human proteins make it a candidate for targeted antimicrobial strategies .

Product Specs

Form
Lyophilized powder
Please note: We will prioritize shipping the format currently in stock. However, if you have specific requirements for the format, please indicate them in your order notes, and we will accommodate your request.
Lead Time
Delivery times may vary depending on the purchase method and location. We recommend consulting your local distributors for specific delivery estimates.
Note: All proteins are shipped with standard blue ice packs. If you require dry ice shipping, please inform us in advance as additional fees may apply.
Notes
Repeated freezing and thawing is not recommended. For optimal results, store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly before opening to ensure the contents are at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final concentration of glycerol is 50%. Customers can use this as a reference.
Shelf Life
Shelf life is influenced by factors such as storage conditions, buffer composition, storage temperature, and the inherent stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. Lyophilized forms have a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is necessary for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type will be determined during the production process. If you have a specific tag type in mind, please inform us, and we will prioritize developing the specified tag.
Synonyms
HI_1495; Uncharacterized protein HI_1495
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-86
Protein Length
full length protein
Species
Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)
Target Names
HI_1495
Target Protein Sequence
MGFSELFTNADGRLSTTASIQFWGFVAATGVLLYSVYLDKPYVPEMFSTFLFACVGTAAT KGVANALSQRREQGKEQGREQGREQE
Uniprot No.

Target Background

Database Links

KEGG: hin:HI1495

STRING: 71421.HI1495

Subcellular Location
Cell membrane; Multi-pass membrane protein.

Q&A

What is the recommended experimental design for initial characterization of HI_1495?

When beginning work with an uncharacterized protein like HI_1495, a systematic experimental approach is essential. Start with a preregistered experimental design that incorporates appropriate controls and establishes clear endpoints. Experimental research design serves as a framework of protocols and procedures created to conduct research with a scientific approach using two sets of variables, where the first set acts as a constant used to measure differences in the second set . For HI_1495 characterization, consider implementing a three-phase design:

  • Preliminary phase: Sequence analysis, structural prediction, and evolutionary conservation assessment

  • Expression phase: Optimizing recombinant expression systems and purification protocols

  • Functional characterization phase: Systematic testing of hypothesized functions based on bioinformatic predictions

When designing these experiments, remember that effective research design helps establish quality decision-making procedures, structures the research to facilitate easier data analysis, and directly addresses the main research question .

What expression systems are most effective for producing recombinant HI_1495?

For recombinant expression of HI_1495, consider the following expression systems based on experimental objectives:

Expression SystemAdvantagesLimitationsRecommended Application
E. coli BL21(DE3)High yield, rapid growth, economicalLimited post-translational modificationsInitial structural studies
H. influenzae Rd KW20Native post-translational modificationsLower yield, more complex cultivationFunctional studies
Mammalian HEK293TComplex folding support, human-like modificationsExpensive, time-consumingHost-pathogen interaction studies

When selecting an expression system, prioritize those that have demonstrated success with other H. influenzae proteins. The transformed recombinant enrichment profiling (TREP) approach described for other H. influenzae proteins can be adapted for HI_1495 characterization, allowing for natural transformation and subsequent phenotypic selection .

How should I design primers for HI_1495 amplification and cloning?

Primer design for HI_1495 amplification requires careful consideration of several factors:

  • Sequence verification: Always confirm the genomic context of HI_1495 using updated genomic databases to ensure targeting the correct sequence.

  • Restriction site integration: Include appropriate restriction sites with 4-6 base overhangs for efficient digestion.

  • Fusion tag compatibility: Consider adding sequences for His-tags, GST, or other fusion partners based on downstream applications.

  • Codon optimization: Adapt codons based on your expression system to improve translation efficiency.

For optimal results, design primers with annealing temperatures between 58-62°C and verify specificity using tools like Primer-BLAST. Include control primers targeting conserved H. influenzae housekeeping genes to validate your PCR conditions.

How can I resolve contradictory data when characterizing HI_1495 function?

Contradictory results are common when working with uncharacterized proteins and require systematic resolution approaches. When facing conflicting data regarding HI_1495 function, implement this structured resolution framework:

  • Methodological validation: Verify that all experimental techniques were performed with appropriate controls and standardized protocols.

  • Independent replication: Have different researchers repeat key experiments using the same protocols.

  • Orthogonal approach integration: Apply different techniques that measure the same parameter through different mechanisms.

  • Condition dependency analysis: Systematically vary experimental conditions to identify factors influencing variable results.

Remember that data presentation should align with interpretation, avoiding redundant qualitative descriptors like "remarkably" or "extremely" when presenting statistical results . Let the numerical data demonstrate the significance of your findings.

What computational approaches can predict HI_1495 function in the absence of structural data?

In the absence of experimental structural data, several computational approaches can generate functional hypotheses for HI_1495:

Computational MethodApplicationOutputReliability Score
Position-Specific Scoring MatrixSequence conservationConserved domainsHigh for conserved regions
Hidden Markov ModelsRemote homology detectionPotential functional familiesMedium
Molecular DynamicsStructural predictionConformational dynamicsMedium-low
Machine Learning AlgorithmsIntegrated predictionFunction probabilityVariable (context-dependent)

When implementing these approaches, validate predictions across multiple algorithms and databases. For HI_1495, special attention should be paid to potential adhesin-like functions, given the importance of adhesins like HMW1 in H. influenzae pathogenesis . The TREP method described in the literature can be particularly valuable for identifying functional domains in HI_1495 by generating complex pools of recombinants and using deep sequencing to survey genetic variations responsible for phenotypic changes .

How can I investigate potential roles of HI_1495 in intracellular invasion?

Given that some H. influenzae proteins are implicated in intracellular invasion and persistence during chronic infection, investigating similar roles for HI_1495 requires careful experimental design. Based on approaches used for HMW1 adhesin characterization , implement the following methodology:

  • Genetic manipulation: Create knockout and complementation strains using natural transformation methods.

  • Invasion assays: Quantify intracellular bacterial counts using gentamicin protection assays with appropriate airway epithelial cell models.

  • Microscopy validation: Use immunofluorescence to visualize invasion patterns and potential bacterial aggregation during invasion.

  • Comparative analysis: Compare invasion phenotypes between wild-type, mutant, and complemented strains under various conditions.

When analyzing invasion data, remember that bacterial self-aggregation and adherence may influence invasion rates, so these phenotypes should be measured independently to determine whether they contribute to or are independent of invasion mechanisms .

What are the optimal methods for purifying recombinant HI_1495?

Purification strategies for recombinant HI_1495 should be tailored to both the expression system and downstream applications:

Purification MethodApplicationAdvantagesConsiderations
Immobilized Metal Affinity ChromatographyHis-tagged HI_1495High specificity, single-stepTag may affect function
Size Exclusion ChromatographyOligomerization studiesNative conditions, multimer separationLower resolution for similar sizes
Ion Exchange ChromatographyTag-free purificationNo tag interferenceOptimization required for each batch
Affinity ChromatographyInteraction partner studiesCo-purification of complexesRequires known binding partners

For optimal results, implement a multi-step purification strategy beginning with capture chromatography (typically IMAC for His-tagged constructs) followed by polishing steps. Verify purification efficiency at each stage using SDS-PAGE and western blotting to track protein recovery and purity.

How should I design experiments to detect protein-protein interactions involving HI_1495?

When investigating interaction partners of HI_1495, employ multiple complementary approaches:

  • Co-immunoprecipitation: Use anti-HI_1495 antibodies or tag-based pulldown to identify interacting partners in cell lysates.

  • Bacterial two-hybrid systems: Adapt for prokaryotic protein interactions to screen for potential partners.

  • Surface plasmon resonance: Determine binding kinetics and affinity constants for specific interactions.

  • Proximity labeling: Use BioID or APEX2 fusions to HI_1495 to identify proximal proteins in the native environment.

Data presentation for interaction studies should follow the general rule of keeping it simple while providing comprehensive information . Present the data first in general terms, then move to specifics, ensuring that the information directly addresses your research questions .

What statistical approaches are appropriate for analyzing HI_1495 functional assay results?

Statistical analysis of functional assay data for HI_1495 should follow these principles:

  • Appropriate test selection: Choose statistical tests based on data distribution (parametric vs. non-parametric) and experimental design (paired vs. unpaired).

  • Multiple comparison correction: Apply Bonferroni or false discovery rate corrections when performing multiple comparisons.

  • Effect size reporting: Include not only p-values but also confidence intervals and effect sizes to demonstrate biological significance.

  • Replication validation: Verify consistency across biological replicates before combining data.

When presenting statistical results, avoid redundant phrases like "it is clearly evident" or "there was significant difference." Instead, simply state "Statistical significant difference was observed" followed by the specific conditions .

How can I integrate multiple experimental datasets to build a comprehensive understanding of HI_1495?

Integrating diverse experimental data requires a systematic approach:

Data TypeIntegration MethodOutputApplication
Sequence AnalysisComparative GenomicsConservation PatternsFunctional Domain Prediction
Expression DataCorrelation AnalysisCo-expression NetworksFunctional Pathway Inference
Interaction DataNetwork MappingProtein-Protein Interaction NetworksFunctional Context
Phenotypic DataMulti-parametric AnalysisPhenotypic ClustersFunctional Verification

For HI_1495, implement a data integration workflow that begins with sequence-based predictions, followed by experimental validation through expression studies, and culminating in phenotypic characterization. The TREP methodology provides an excellent framework for integrating genomic and phenotypic data by linking genetic variation to observable traits through transformation, selection, and deep sequencing .

How should I use Google's "People Also Ask" data to guide my HI_1495 research?

Google's People Also Ask (PAA) feature can provide valuable insights into research trends and knowledge gaps regarding HI_1495:

  • Identify knowledge gaps: Analyze questions that appear frequently but lack comprehensive answers in the literature.

  • Understand research priorities: Note which aspects of the protein (structure, function, expression) generate the most interest.

  • Discover related topics: Identify connections between HI_1495 and other biological systems or diseases.

  • Track evolving interests: Monitor changes in PAA questions over time to detect shifting research priorities.

PAA data appears in over 80% of English searches, generally within the first few results, making it a valuable resource for understanding how the research community conceptualizes HI_1495 . The cascading nature of PAA results, where clicking one question reveals additional related questions, can help map the conceptual landscape surrounding HI_1495 research .

How can I address solubility issues when working with recombinant HI_1495?

Protein solubility challenges are common with recombinant proteins and require systematic troubleshooting:

  • Expression condition optimization: Test various temperatures (16-37°C), induction conditions, and expression durations.

  • Buffer screening: Systematically vary pH (6.0-9.0), salt concentration (50-500mM), and additives (glycerol, detergents).

  • Fusion partner strategy: Test solubility-enhancing tags such as MBP, SUMO, or TRX.

  • Co-expression approaches: Consider co-expressing with chaperones or binding partners.

Document each optimization attempt in a structured format, recording all parameters and outcomes. This methodical approach will help identify patterns that influence HI_1495 solubility and guide further optimization efforts.

What are the best approaches for generating specific antibodies against HI_1495?

Developing specific antibodies against HI_1495 requires careful antigen design and validation:

Antibody Development StageKey ConsiderationsRecommended Approach
Antigen DesignEpitope accessibility, uniquenessUse multiple peptides from distinct regions
Immunization StrategySpecies selection, adjuvant choiceUtilize multiple host species with different protocols
Screening MethodSpecificity verificationTest against recombinant protein and native H. influenzae lysates
ValidationCross-reactivity assessmentTest against related proteins and knockout controls

When validating antibody specificity, always include appropriate controls including pre-immune serum, irrelevant antibodies of the same isotype, and when possible, samples from HI_1495 knockout strains to confirm specificity.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.